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1✉

During ontogeny, macrophage populations emerge in the Yolk Sac (YS) via two distinct
progenitor waves, prior to hematopoietic stem cell development. Macrophage progenitors
from the primitive/”early EMP” and transient-deﬁnitive/”late EMP” waves both contribute to
various resident primitive macrophage populations in the developing embryonic organs.
Identifying factors that modulates early stages of macrophage progenitor development may
lead to a better understanding of defective function of speciﬁc resident macrophage subsets.
Here we show that YS primitive macrophage progenitors express Lyl-1, a bHLH transcription
factor related to SCL/Tal-1. Transcriptomic analysis of YS macrophage progenitors indicate
that primitive macrophage progenitors present at embryonic day 9 are clearly distinct from
those present at later stages. Disruption of Lyl-1 basic helix-loop-helix domain leads initially to
an increased emergence of primitive macrophage progenitors, and later to their defective
differentiation. These defects are associated with a disrupted expression of gene sets related
to embryonic patterning and neurodevelopment. Lyl-1-deﬁciency also induce a reduced
production of mature macrophages/microglia in the early brain, as well as a transient
reduction of the microglia pool at midgestation and in the newborn. We thus identify Lyl-1 as
a critical regulator of primitive macrophages and microglia development, which disruption
may impair resident-macrophage function during organogenesis.
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mongst the components of the transcription factor network that regulate hematopoietic cells features, Tal-1,
Lmo2, Runx1, and Gata2 stand out as major regulators of
hematopoietic progenitor development1,2. Tal-1, Lmo2, and
Gata-2 belong to a transcriptional complex, which also includes
the basic helix–loop–helix (bHLH) transcription factor lymphoblastic leukemia-derived sequence 1 (Lyl-1). Unlike its paralog
Tal-1, which is mandatory for the speciﬁcation of all hematopoietic progenitors3,4, Lyl-1 roles during developmental hematopoiesis remains poorly characterized. We analyzed these
functions at the onset of YS hematopoietic development using
Lyl-1LacZ/LacZ mutant mice5.
During ontogeny, hematopoietic progenitors are generated in three
successive and overlapping waves6,7. The emergence of the Hematopoietic Stem Cells (HSC) that will maintain lifelong hematopoiesis
in the adult occurs at mid-gestation in the third and deﬁnitive
hematopoietic wave. HSC generated in the aorta region immediately
migrate to the fetal liver (FL) where they mature and amplify before
homing to the bone marrow before birth8,9. Prior to HSC generation,
the production of blood cells relies on two hematopoietic waves
provided by the YS. This HSC-independent hematopoiesis comprises
ﬁrst the primitive hematopoietic wave, with the transient production

2

of progenitors with embryonic speciﬁc features: From Embryonic day
(E) 7.00, the YS produces monopotent progenitors for erythrocytes,
megakaryocytes and macrophages (MΦ)10,11, along with bipotent
Erythro-Megakaryocytic progenitors12, in a Myb-independent
pathway13,14. The second YS wave, called transient-deﬁnitive, provides for a limited duration progenitors (mostly erythro-myeloid)
that seed the FL and produce a hematopoietic progeny that displays
deﬁnitive/adult differentiation features. Erythro-myeloid cell production in this wave occurs in a Myb-dependent pathway, through
the progressive differentiation of erythro-myeloid progenitors (EMP)
in a pathway similar to the adult one6. As primitive and transient
deﬁnitive YS waves both produce cells from erythro-myeloid lineages,
they are also termed respectively “early EMP” and “late EMP”15,16.
Considering the MΦ lineage, fate-mapping approaches aimed
at determining the embryonic origin of resident-MΦs indicated
that most tissues harbor resident-MΦs of diverse origins (YS, FL
and adult bone marrow)15,17,18, which complicates the characterization of wave-dependent functions of the various subsets.
However, these fate-mapping analyses established that, contrary
to others tissue, brain MΦs (microglia and Border Associated MΦ
(BAM)) develop only from YS-derived MΦ-progenitors14,16,19–21,
conﬁrming a model we previously put forward22. Due to the
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Fig. 1 Lyl-1 expression marks MΦPrim progenitors in the early YS. a Lyl-1-deﬁciency leads to an increased production of MΦ-progenitors in the early YS:
Clonogenic potential of E8 OrgD1-YS cells: production of MΦ-progenitors (MΦP) in WT, Lyl-1WT/LacZ and Lyl-1LacZ/LacZ OrgD1-YS. Distribution of other
progenitors with a myeloid potential (EMP and GM) in WT, Lyl-1WT/LacZ and Lyl-1LacZ/LacZ E8 OrgD1-YS. (n = 3–5, 3–6 YS per sample; mean ± s.e.m.;
Unpaired, two-tailed t-test). b Lyl-1 expression in MΦ-progenitors: FACS-Gal assay, using the β-Gal ﬂuorescent substrate FDG, was used as a reporter for
Lyl-1 expression. While all MΦ-progenitors in E9-YS expressed FDG/Lyl-1, E9.5 and E10-YS harbored two MΦ-progenitor subsets discriminated by their
FDG/Lyl-1 expression. FDG+/Lyl-1+ and FDG-/Lyl-1- mature MΦs (CD11b+F4/80+) also coexisted in E10-YS. The contour plots in WT samples indicate
the level of non-speciﬁc background β-Gal activity/FDG labeling in WT samples. Representative proﬁles of 3 independent samples, each consisting of 3–4
YS (see gating strategy in Supplementary Fig. 1a). c In clonogenic assays, the number of MΦ-progenitors obtained from E8-YS (0-3 Somites) was increased
in Lyl-1WT/LacZ and Lyl-1LacZ/LacZ compared to WT. The majority of the 25–30 progenitors per YS were EryP (60 to 80% in each 3 genotypes). Other
progenitors were occasionally and randomly detected in WT and mutant samples (less than one EMP (0.81% ± 0.66; n = 3) and/or GM progenitor per E8YS), conﬁrming that the assay was performed at a time when MΦT-Def progenitors were absent. (n = 3–4, 5–10 YS per sample; error bars show
mean ± s.e.m.; Unpaired, two-tailed t-test). d MΦPrim progenitors express Lyl-1. Flow cytometry proﬁles of WT and Lyl-1WT/LacZ E8-YS (0-3 S). CD11b
+CD31- MΦs correspond to maternal MΦs present in E8-YS11. All CD11b+CD31+ MΦ-progenitors displayed FDG/Lyl-1 expression (Red line). The contour
plots in WT samples indicate the level of non-speciﬁc background β-Gal activity/FDG labeling in WT samples. Shown are representative proﬁles of 4
independent experiments. e RT-qPCR quantiﬁcation of Myb expression levels: Kit+CD45+CD11b+ progenitors were sorted from WT E9-YS, WT and Lyl1WT/LacZ E10-YS, and from FDG/Lyl-1 positive and negative fractions of MΦ-progenitors from Lyl-1WT/LacZ E10-YS. Lin-Sca+Kit+ (LSK) progenitors from
WT E12-FL were used as positive control. FDG+/Lyl-1+ MΦ-progenitors from E10-YS expressed MybLow/Neg levels similar to MΦPrim progenitors from E9YS. The FDG-/Lyl-1- fraction expressed signiﬁcantly higher Myb levels, similar to LSK cells from E12-FL. Myb expression levels, shown on a Log2 scale, were
normalized to the mean expression value obtained for WT E10-YS, considered as 1 (Each dot represent an independent experiment; Error bars show
means ± s.e.m; Unpaired, two-tailed t-test). f FDG/Lyl-1 positive and negative myeloid progenitors produce a distinct progeny: Clonogenic assays
characterization of the type of progenitors produced by myeloid progenitors (Ter119-Kit+CD45+CD11b+) sorted from WT and Lyl-1WT/LacZ E9-YS ( < 18 S;
n = 7) and E10-YS (n = 15) in 3 independent experiments. At E10, myeloid progenitors from Lyl-1WT/LacZ YS were subdivided into FDG/Lyl-1 negative
(n = 15) and positive (n = 12) fractions (5 independent experiments). Samples were biological replicates comprising 6–8 YS. 100 to 150 Kit+CD45+CD11b+
cells per condition were platted in triplicate. All samples produced few non-myeloid contaminants, such as Erythro-Megakaryocytic progenitors and EMP in
similar, non-signiﬁcant amounts. FDG+/Lyl-1+ progenitors essentially produced MΦ−progenitors (MΦP), while FDG-/Lyl-1- progenitors produced also
granulo-monocytic- (GMP) and granulocyte- (GP) progenitors. Error bar shows means ± s.e.m.

coexistence of two waves in the YS, the origin of microglia
has been debated (reviewed in refs. 6,15,18,23). An origin of
microglia from MΦ-progenitors from the primitive/”early EMP”
wave was supported by microglia labeling following an early
(E7.0-E7.5) CRE-mediated induction of Runx119 and by the
intact microglia pool in Myb-deﬁcient mice14,21. The origin of
microglia was also attributed to the primitive wave in zebraﬁsh
embryos, since primitive macrophage (MΦPrim) progenitors arise
in this species from a location distinct from other hematopoietic
progenitors24–26. Finally, the normal microglia development in
mice lacking Kit ligand, leading to an impaired EMP development
and the depletion of resident-MΦs in the skin, lung, and liver
supports this model27.
We here show that, at the early stages of YS hematopoiesis, Lyl1 expression characterizes primitive MΦ-progenitors. Through
RNA-seq. analyses, it appears that these primitive MΦprogenitors harbor an immune-modulatory phenotype, while
those produce at a later stage favor the inﬂammatory signaling
which promotes the emergence of HSC in the third and deﬁnitive
hematopoietic wave28.
Our results also indicate that in the brain, Lyl-1 is expressed
in the entire microglia/BAM cell population at the onset
of brain colonization and appeared to regulate microglia/BAM
development.
Altogether, these data point to Lyl-1 as a major regulator of
early embryonic MΦ-progenitors development and advocate for
further analyses to more precisely delineate Lyl-1 function during
the development of resident-MΦs in homeostatic and pathological contexts.
Results and discussion
Lyl-1 expression marks MΦPrim progenitors from the early YS.
Lyl-1 being expressed in the YS from the onset of YS
hematopoiesis29, we ﬁrst explored its function by characterizing
the clonogenic potential of WT, Lyl-1WT/LacZ and Lyl-1LacZ/LacZ
YS. E8-YS were maintained in organ culture for 1 day (E8
OrgD1-YS), allowing only the development of primitive and

transient-deﬁnitive progenitors30,31. Compared to WT, the production of MΦ progenitors was increased in Lyl-1WT/LacZ and
Lyl-1LacZ/LacZ OrgD1-YS. Otherwise, the clonogenic potential and
progenitor distribution were unmodiﬁed (Fig. 1a).
Using FACS-Gal assay, we noticed that the entire MΦprogenitor population (Kit+CD45+CD11b+) expressed Lyl-1 at
E9. In contrast, two MΦ-progenitor subsets, discriminated by
FDG/Lyl-1 expression, were present after E9.5 (Fig. 1b). Since
after E9.5, the YS harbors both MΦPrim and transient-deﬁnitive
(MΦT-Def) MΦ−progenitors, and as these progenitor subsets
cannot be discriminated by phenotype11, we investigated the
known features discriminating these two waves: the origin from
monopotent progenitors for MΦPrim progenitors10,11 and the
Myb-dependent14,32 differentiation of MΦT-Def progenitors from
EMP, via the production of granulo-monocytic (GM-), then
granulocyte (G-) and MΦ-progenitors6.
At E8 (0-5 somites), when the YS only harbors MΦPrim
progenitors, clonogenic assays also pointed to an increased
production of MΦ-progenitors in mutant E8-YS compared to WT
(Fig. 1c). At this stage, all MΦ-progenitors, which harbor a CD11b+
CD31+ phenotype11, expressed FDG/Lyl-1 (Fig. 1d). Most FDG+/
Lyl-1+ CD11b+CD31+ cells (69.27%±0.33%) from Lyl-1WT/LacZ E8YS reliably produced MΦ colonies (72.78 ± 9.65%; n = 3) in
clonogenic assays, amounting 1-4 MΦ progenitors per YS, a value
consistent with previously published data10,11.
Lyl-1 expression by MΦPrim progenitors was strengthened by RTqPCR comparison of Myb expression: Both E9-YS MΦPrim
progenitors and FDG+/Lyl-1+ progenitors from E10-YS expressed
low Myb levels strengthening their primitive status, while FDG-/Lyl1- progenitors from E10-YS progenitors displayed Myb levels similar
to lineage-negative Sca1+Kit+ progenitors from E12-FL (Fig. 1e).
The differentiation potential of FDG+/Lyl-1+ and FDG-/Lyl-1fractions of Ter119-Kit+CD45+CD11b+ myeloid progenitors
isolated from E10-YS also pointed to Lyl-1 expression by MΦPrim
progenitors (Fig. 1f): Similar to WT E9-YS MΦPrim progenitors,
E10 FDG+/Lyl-1+ progenitors appeared monopotent, as
they nearly exclusively produced MΦ colonies. In contrast, E10
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FDG-/Lyl-1- myeloid progenitors produced GM, G and MΦ
colonies, a feature typical of transient-deﬁnitive progenitors6.
Overall, these data together suggested that Lyl-1 may mark
MΦPrim progenitors from the earliest wave.
Distinct features of WT MΦ-progenitors at E9 and E10. The
distinction between E9 and E10 MΦ-progenitors was conﬁrmed
4

in RNA-seq. analysis of CD45+CD11b+Kit+ MΦ-progenitors
sorted at E9 (MΦPrim progenitors) and E10 (MΦPrim and
MΦT-Def progenitors). Principal Component Analysis separated
E9 and E10 MΦ-progenitors according to stage and genotypes
(Fig. 2A). E9 and E10 WT MΦ-progenitors differed by the
expression of 726 genes, 176 being up-regulated at E9 and 550 at
E10. Considering the coexistence of MΦPrim and MΦT-Def
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Fig. 2 Distinct features of WT MΦ-progenitors at E9 and E10. A Differentially expressed genes in MΦ-progenitors (Kit+CD45+CD11b+) sorted from WT
and Lyl-1LacZ/LacZ YS at E9 and E10. Unsupervised principal component analysis plot positioned E9 and E10 MΦ-progenitors in two distinct groups, followed
by segregation of WT and Lyl-1LacZ/LacZ samples. Volcano plot of E9 WT vs E10 WT MΦ-progenitors: Red and green dots indicate genes with statistically
signiﬁcant changes in expression level. (p-value < 0.05, absolute fold change≥2.0) (NDE: not deregulated genes; DE-Up: up-regulated genes; DE-Down:
down-regulated genes). B Venn diagram comparing differentially expressed genes in E9 WT vs E10 WT MΦ-progenitors to the EMP or MΦ signatures
deﬁned by Mass et al.33 (GEO accession number GSE81774). The number and percentage of differentially expressed genes common to the EMP or MΦ
signatures is shown. Expression proﬁles of the overlapping genes identiﬁed in the Venn diagram (Heatmap displays transformed log2-expression values;
Unpaired t-test, two-tailed). Note the higher expression at E10 of genes involved in erythroid (Globins: Pink arrow; Transcription factors: green arrow), and
megakaryocytic and granulocytic-related genes (blue arrow), and of Mrc1/CD206 (Asterisk). C Relative expression levels of Gata1 and Spi1/PU.1, indicated
by their relative Transcripts per million kilo-bases. D Enriched pathways in E9 and E10 WT MΦ-progenitors with absolute z-score ≥2, from QIAGEN’s
Ingenuity® Pathway Analysis. Bars: minus log of the p-value of each canonical pathway; Orange line: threshold p-value of 0.05. Ratio: genes detected/genes
per pathway. E Expression proﬁles of differentially expressed genes related to IFNγ and IFNβ response, identiﬁed by g:Proﬁler (heatmap displays
transformed log2-expression values; unpaired t-Test, two-tailed). F Expression proﬁles of differentially expressed genes related to MHC-II complex
(Heatmap displays transformed log2-expression values; unpaired t-Test, two-tailed). G Expression proﬁles of differentially expressed genes related to
cytokine signaling (Heatmap displays transformed log2-expression values; unpaired t-Test, two-tailed).

progenitors in E10-YS, differentially expressed genes found at E10
may reﬂect wave-speciﬁc differences or stage-dependent changes
related to MΦPrim progenitor maturation.
Overlapping the identiﬁed differentially expressed genes to the
EMP and E10.25-E10.5 MΦs signatures obtained by Mass et al.33
conﬁrmed that WT E9 MΦPrim progenitors were distinct from
these two populations, since none of the 176 genes upregulated at
E9 belonged to these signatures. Comparatively, about 5% of the
genes up-regulated at E10 belonged to the EMP and MΦ
signatures (Fig. 2B). A similar separation was observed in GSEA
analyses (Supplementary Fig. 1b). These observations suggest that
within E10 MΦ-progenitors some, likely the MΦT-Def ones, retain
part of the EMPs signature.
In a WT context, E9 MΦPrim progenitors differed from E10
MΦ-progenitors by their transcription factors repertoire. Genes
regulating erythroid development (Gata1, Gata2, Klf1) and globin
genes, embryonic (Hbb-bh1, Hba-x, Hbb-y) and deﬁnitive (Hbaa2, Hba-a1, Hbb-bt), were enriched at E10 (Fig. 2B), while Spi1/
PU.1 was highly expressed compared to Gata1 at both stages
(Fig. 2C). The lower expression level at E9 of erythroid genes and
of genes involved in granulo-monocytic (Mpo, Csf2r/GM-CSF
receptors, Cebp, Jun) and megakaryocytic development (Pf4, TPO
signaling) (Fig. 2B; Supplementary Table 1) sustains the
monopotent/primitive status of E9 MΦ-progenitors, and suggests
that MΦT-Def progenitors may retain the expression of genes that
characterize their EMP ancestor.
Due to the simultaneous presence of MΦPrim and MΦT-Def
progenitors in E10-YS, the differential expressions of markers
that are wave-speciﬁc at these stages (Primitive: Lyl-1; transientdeﬁnitive: Myb and Tlr234) were not signiﬁcant despite a
tendency to decrease for Lyl-1 and increase for Myb and Tlr2
(Supplementary Fig. 1c).
IPA and GSEA analyses indicated that E9 MΦPrim progenitors
were more active in Eicosanoid signaling than E10 progenitors
(Fig. 2D). They were also enriched in type I interferon (IFN) β and
type II IFNγ signaling (Fig. 2E) and in MHC-II related genes,
especially Cd74 (top 1 IPA network) (Fig. 2F; Supplementary Fig. 1d).
Cytometry analyses conﬁrmed a low, but signiﬁcant, enrichment of
MHC-II expression at E9, compared to E10 (Supplementary Fig. 1e).
Comparatively, E10 MΦ-progenitors were more active in inﬂammatory signaling (Fig. 2D, E; Supplementary Fig. 1d, f–h; Supplementary
Table 1), and metabolically active (Supplementary Table 1). The
complement cascade and phagocytosis also prevailed at E10
(Supplementary Fig. 1i, j).
Altogether, the signature for WT E9 MΦPrim progenitors
points to an immuno-modulatory function, while E10 MΦprogenitors appear involved in phagocytosis and inﬂammatory
signaling. Interestingly, inﬂammatory signaling has been revealed

as a key factor favoring embryonic HSC emergence (reviewed in
ref. 35). The source of inﬂammatory signals was further identiﬁed
as MΦ-progenitors expressing Mrc1/CD20636, a marker upregulated in E10 WT MΦ-progenitors compared to E9 (Fig. 2B).
Lyl-1 deﬁciency impacts embryonic development. When evaluating the effect of Lyl-1-deﬁciency at the earliest stage of MΦPrim
development, clonogenic assays pointed to an increased production of MΦ-progenitors in Lyl-1LacZ/LacZ MΦPrim E8-YS compared to WT (Fig. 1c). The analysis of the RNA-seq. comparison
of E9 WT and Lyl-1LacZ/LacZ MΦPrim suggests that the increased
size of the initial MΦ-progenitor pool could results from an
elevated commitment of mesodermal/pre-hematopoietic cells to a
MΦ fate, rather than from a defective differentiation (Supplementary Fig. 2a–d and Supplementary note 1). The high increase
of Itga2b/CD41 expression level in E9 Lyl-1LacZ/LacZ MΦPrim
progenitors (Fig. 3a) may reﬂect this elevated commitment. Lyl-1
expression in YS mesoderm, where it cannot substitute for Tal-1
mandatory function for the generation of hematopoietic
progenitors4, was already established3,29. Recently, Lyl-1 was
identiﬁed as a regulator of mesoderm cell fate37 and of the
maintenance of primitive erythroid progenitors38.
The transcription factors network that controls developmental
hematopoiesis2 was also modiﬁed (Fig. 3b): beside the expected
reduction of Lyl-1 expression, the expression of Lmo2, a Lyl-1
target39, was down-regulated, while Tal-1 up-regulation might
reﬂect some compensatory function3. The consequences were
apparent in GSEA analyses: both pathways and GO terms
uncovered an up-regulation of signaling pathways involved in
embryo patterning (Wnt, Hox and Smad) in Lyl-1LacZ/LacZ MΦprogenitors, as well as a highly modiﬁed collagen, integrin, and
cadherin usage (Supplementary Table 2). Accordingly, developmental trajectories were affected (Fig. 3c), with the up-regulation
in E9 Lyl-1LacZ/LacZ MΦ-progenitors of gene sets related to
“anterior-posterior pattern speciﬁcation” and “anatomical structure formation involved in morphogenesis”, notably skeletal and
nervous system development.
GSEA and KEGG comparison of Lyl-1LacZ/LacZ and WT MΦprogenitors at E10 highlighted another patterning modiﬁcation,
namely the down-regulation of gene sets involved in heart
development (Supplementary Fig. 2e; Supplementary Table 3),
which might stem from a defective MΦ development. The heart
harbors three resident-MΦ subsets, two of which originate from
the YS40. Amongst the features that distinguish WT E9 MΦPrim
progenitors from E10 MΦ-progenitors, the enriched expression
of MHC-II (Fig. 2F) and poor expression of phagocytosis-related
genes (Supplementary Fig. 1i) at E9 also characterize one of the
two YS-derived CCR2- resident-MΦ subsets in the heart40,41.
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Fig. 3 Lyl-1 regulates the production of E8 MΦPrim progenitors. a Relative expression levels of the CD41 coding gene Itg2b in WT and Lyl-1LacZ/LacZ MΦprogenitors at E9 (error bars show mean ± s.e.m.; unpaired t-Test, two-tailed). b Relative expression levels of transcription factors regulating hematopoietic
progenitor emergence in Lyl-1LacZ/LacZ MΦ-progenitors compared to WT at E9 (Error bars show mean ± s.e.m.; unpaired, two-tailed t-Test). c GSEA
pathways (FDR q-value <0.29) and GO terms (FDR q-value < 0.01) enriched in E9 Lyl-1LacZ/LacZ compared to E9 WT MΦ-progenitors. Highlighted are the
pathways speciﬁcally related to embryo patterning (blue) and to the development of skeletal (green) and nervous systems (yellow). Pink arrows point to
changes related to metabolic pathways.

6

COMMUNICATIONS BIOLOGY | (2021)4:1382 | https://doi.org/10.1038/s42003-021-02886-5 | www.nature.com/commsbio

COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02886-5

Therefore, a function for Lyl-1+ MΦPrim progenitors in heart
development may be considered. This observation reinforces the
need to better characterize the contributions of MΦ-progenitors
from both primitive and transient-deﬁnitive waves to tissues
harboring YS-derived resident-MΦs.
The patterning defects highlighted in defective MΦPrim, might
be responsible, at least in part, for the signiﬁcantly decreased litter

ARTICLE

size and increased perinatal lethality observed in Lyl-1LacZ/LacZ
mice compared to WT (Supplementary Fig. 2F), which indicates
the requirement for Lyl-1 during various developmental processes. Whether this function is speciﬁc to mesodermal stage or
related to a patterning function for MΦPrim progenitors remains
to be determined. Other Lyl-1-expressing lineages29,42 might also
participate to impaired development processes in Lyl-1LacZ/LacZ
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Fig. 4 Defective differentiation of Lyl-1LacZ/LacZ MΦ-progenitors from E10-YS. A Distribution of A1-A2 and A3 MΦ subsets in E10-YS from Cx3cr1WT/GFP:
Lyl-1WT/WT, Cx3cr1WT/GFP:Lyl-1WT/LacZ and Cx3cr1WT/GFP: Lyl-1LacZ/LacZ embryos. While the size of the whole MΦ population is similar in the three genotypes, Lyl-1deﬁciency leads to a modiﬁed distribution of the MΦ subsets with an increased size of the A1 subset and a reduced A3 pool (5–12 independent analyses, 6-8 YS
per sample; Plots show mean ± s.e.m.; Unpaired, two-tailed t-Test). B GSEA pathway indicates a deﬁcit in Jak1-Stat signaling in Lyl-1LacZ/LacZ MΦ-progenitors
compared to WT at E9 (NES: normalized enrichment score; FDR: false discovery rate). C Relative expression levels (read counts) of hematopoietic markers in WT
and Lyl-1LacZ/LacZ MΦ-progenitors at E9 (Error bars show mean ± s.e.m.; unpaired t-Test, two-tailed). D Top 1 GSEA pathway indicates that the IFN signaling
pathway, which characterize E9 MΦPrim progenitors, is defective in Lyl-1LacZ/LacZ MΦ-progenitors (NES: normalized enrichment score; FDR: false discovery rate).
The expression of Irf8 is particularly affected (error bars show mean ± s.e.m.; unpaired t-test, two-tailed). E From the 53 canonical pathways identiﬁed by Ingenuity®
Pathway Analysis as differentially expressed, 9 were enriched with an absolute Z score ≥ 1. Bars: minus log of the p-value of each canonical pathway; Orange line:
threshold p-value of 0.05. Ratio: genes detected/genes per pathway. F Venn diagram comparing the differentially expressed genes in E9 Lyl-1LacZ/LacZ vs E9 WT to
those in E10 Lyl-1LacZ/LacZ vs E10 WT MΦ-progenitors. Expression proﬁles of the differentially expressed genes common to both stages identiﬁed by the Venn
comparison (Heatmap displays transformed log2-expression values; unpaired t-Test, two-tailed). G Relative expression levels (read counts) of phagocytosis genes
in WT and Lyl-1LacZ/LacZ MΦ-progenitors at E10 (Box and whisker plots, min to max; median is shown; two tailed, unpaired Mann–Whitney test).

embryos, calling for the development of new mouse models that
will allow lineage speciﬁc reports of Lyl-1 expression and function
in endothelial or hematopoietic lineages during discrete steps of
early YS development and beyond.
Defective MΦPrim development in Lyl-1 mutant YS. The analysis of Lyl-1 expression in A1-A2-A3 subsets from Cx3cr1WT/GFP
YS indicated that Lyl-1 is expressed throughout MΦ-progenitor
differentiation, with levels decreasing from A1 to A3 (Supplementary Fig. 3a). We monitored the distribution of A1-A2 and
A3 MΦ subsets (Supplementary Fig. 2a) at E10-YS, when all three
subsets are present, using the Cx3cr1WT/GFP:Lyl-1LacZ/LacZ strain.
While the size of the whole MΦ population was not overtly
modiﬁed, Lyl-1-deﬁciency impacted the subset distribution, with
increased A1 and reduced A2 and A3 pool sizes (Fig. 4A). Lyl-1
thus appears to regulate MΦ differentiation towards mature MΦs.
A limited/delayed differentiation of E9 Lyl-1LacZ/LacZ MΦPrim
progenitors could result from an altered cytokine signaling: Signaling through Jak-Stat pathway (Jak1-Stat1/6), which underlays
cytokine signaling in hematopoietic cells, was down-regulated In
E9 mutant progenitors, (Fig. 4B; Supplementary Fig. 3b), with
profoundly decreased expression of interleukins and their
receptors (Il1a-b/Il1r1-2; Il4i1/Il4Ra; Il6st/Il6ra; Il10/ Il10ra). It
was also supported by a down-regulated Spi1/PU.1 signaling
pathway (Supplementary Fig. 3c; Supplementary Tables 4–5) and
by the decreased expression of Ptprc/CD45, Csf1r, Itgam/CD11b
and CD33 (Fig. 4C).
Within the MΦ lineage, Lyl-1 function during normal
development would initially consist to restrict the size of the
MΦPrim progenitor pool and/or the duration of its production,
which is transient6, as indicated by the maintenance of the
intermediate mesoderm to MΦ-progenitor pool observed in Lyl1LacZ/LacZ E8-YS. Indeed, the increased size of the MΦ-progenitor
pool in E8-E9 YS appears independent from the defective/delayed
differentiation of MΦ-progenitors observed at E10, since this
process starts after E9.510,11,15. Subsequently, the increased size of
MΦPrim progenitor pool in E10 Lyl-1LacZ/LacZ YS likely results
from a defective/delayed differentiation mediated by a defective
cytokine signaling, implying that during normal development,
Lyl-1 would promote the differentiation of MΦPrim progenitors.
Lyl-1LacZ/LacZ MΦ-progenitors were also deﬁcient in the IFN
signaling that characterize E9 MΦPrim progenitors, notably Irf8, a
factor involved in YS-MΦ and microglia development21,43
(Fig. 4D). Compared to WT, MΦ-progenitors from Lyl-1LacZ/
LacZ E9-YS up-regulated the LXR/RXR activation pathway
(Fig. 4E) and metabolic pathways, some enriched WT MΦprogenitors at E10 (Butanoate, steroid) (Supplementary Table 1),
and other not (Fructose/mannose, fatty acid) (Fig. 3c). They were
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also less active in inﬂammatory signaling pathways, particularly
through NFκb, a factor known to interact with Lyl-144, and in
TLR signaling (Fig. 4D; Supplementary Fig. 3b, d–e; Supplementary Table 5).
Overlapping the differentially expressed genes identiﬁed in Lyl1LacZ/LacZ MΦ-progenitors at E9 and E10 identiﬁed the core
signature of Lyl-1-deﬁciency, independent of the maturation
occurring between these stages (Fig. 4F). Unfortunately, the coexistence of MΦPrim and MΦT-Def progenitors in E10-YS
complicates the attribution of gene expression changes to a
stage-dependent maturation of MΦPrim progenitors or to a
signature speciﬁc to MΦT-Def progenitors. However, most
pathways favored by E10 progenitors were insensitive to Lyl-1deﬁciency, except for a decreased expression of phagocytosis
genes (Axl1, Mertk, Trem2, P2y6r/P2ry6) (Fig. 4G). Conversely,
the TLR signaling pathway was increased in Lyl-1LacZ/LacZ MΦprogenitors at E10, compared to E9.

Lyl-1-expressing MΦ-progenitors contribute to the fetal liver
and brain. The FL9 and brain19,22 are colonized as early as E9 by
YS-derived resident-MΦ progenitors. We evaluated the contribution of Lyl-1-expressing MΦPrim progenitors to these rudiments at E10 (Fig. 5A). While E10-YS comprised FDG+/Lyl-1+
and FDG-/Lyl-1- MΦ-progenitors and mature (F4/80+) MΦ
subsets (Fig. 1b), the brain from the same embryos essentially
harbored FDG+/Lyl-1+ MΦ-progenitors and MΦs. In contrast,
both FDG+/Lyl-1+ and FDG-/Lyl-1- MΦ-progenitors were present in E10-FL, as in E10-YS, and MΦ-progenitors were more
abundant in mutant FL than in WT (Fig. 5B).
We next focused on brain MΦs during the colonization stage,
which lasts until E1145. At this stage, microglia and perivascular,
meningeal and choroid plexus MΦs, collectively referred to as
BAMs, are all located in the brain mesenchyme and therefore
undistinguishable16,46. FACS-Gal assay demonstrated that the
whole F4/80+ microglia/BAM expressed Lyl-1 throughout the
settlement period (Fig. 5C). The presence of FDG+/Lyl-1+F4/80+
microglia/BAM at early stage of brain colonization suggests that
MΦs could participate to this step.
Lyl-1+ MΦPrim progenitors and early microglia/BAM shared
similar features, such as an early appearance timing and low level
of Myb expression (Fig. 5D), concordant with a Myb-independent
development of microglia14,21. Lyl-1 was also similarly expressed
in A1-A2 and A3 MΦ subsets from the YS and brain (Fig. 5E;
Supplementary Fig. 3a). Lyl-1-deﬁciency impacted the distribution of MΦs subsets in E10 Cx3cr1WT/GFP:Lyl-1LacZ/LacZ brain: an
increased A1 and a reduced A3 pool size indicated that Lyl-1
regulates MΦ-progenitor differentiation in both YS and brain
(Fig. 5F).
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The proximity between YS MΦPrim progenitors and microglia
was also apparent in RNA-seq. data: E9 WT MΦPrim
progenitors expressed signiﬁcantly lower Mrc1/CD206 and
higher Sall3 levels than E10 MΦ-progenitors, and a slightly
increased Sall1 level (Fig. 5G), a transcriptomic pattern that
characterizes microglia33,45,47. This partial bias toward a
microglia signature suggests that the ﬁrst stage of microglia
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development program is already initiated in MΦPrim /“early
EMP”progenitors in E9-YS.
Lyl-1 inactivation impairs microglia development at two
development stages. Having deﬁned Lyl-1 implication during
microglia/BAM settlement in the brain, we turned to later
development stages. Cytometry and database analyses45
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Fig. 5 Contribution of Lyl-1-expressing MΦ-progenitors to the fetal liver and brain. A All MΦ-progenitors from E10-Brain expressed Lyl-1, contrary to the
corresponding YS (Fig. 1b) which harbor both FDG+/Lyl-1+ and FDG-/Lyl-1- subsets. MΦ-progenitors from E10 Lyl-1LacZ/LacZ FL harbored both FDG+/Lyl1+ and FDG-/Lyl-1 MΦ-progenitor subsets. in E10-brain, mature MΦs (CD11b+F4/80+ gate) were all FDG+/Lyl-1+. The contour plots in WT samples
indicate the level of non-speciﬁc background β-Gal activity/FDG labeling in WT samples. Representative proﬁles of 3 independent samples, each consisting
of 3-4 E10-Brain or 8-12 E10-FL. B Quantiﬁcation of Kit+CD45+CD11b+ MΦ-progenitors in E10-FL (plots show mean ± s.e.m.; Unpaired, two-tailed t-Test).
C Lyl-1 marks the entire F4/80 + microglia/BAM population from the onset of brain colonization. FDG/Lyl-1 expression in F4/80+ microglia/BAM from
the brain of Lyl-1WT/LacZ and Lyl-1LacZ/LacZ embryos at E9 to E11. The rare CD11b+ F4/80low-neg cells present in the brain at E9 are FDG+/Lyl-1+. Gray
histograms indicate non-speciﬁc background β-Gal activity/FDG levels in WT samples. Representative proﬁles of 3–5 independent samples, each
consisting of 3-5 brains. D MΦ-progenitors from E10-brain express Myb levels similar to E9-YS MΦPrim progenitors. RT-qPCR quantiﬁcation of Myb
expression levels in Kit+CD45+CD11b+ MΦ-progenitors sorted from WT E9-YS and from WT and Lyl-1WT/LacZ brain at E10. Lin-Sca+cKit+ (LSK)
progenitors from WT E12-FL were used as positive control. Myb expression levels, shown on a Log2 scale, were normalized to the mean expression value
obtained for WT E10-YS, considered as 1 (error bars show mean ± s.e.m.; Unpaired, two-tailed t-Test). E RT-qPCR analyses of Lyl-1 expression in A1 to A3
MΦ subsets isolated from Cx3cr1WT/GFP brain at E10. Lyl-1 is expressed by the 3 subsets, with levels decreasing with differentiation. Expression levels were
normalized to the mean value obtained for Cx3cr1WT/GFP YS A1 progenitors (n = 2; Error bars show mean ± s.e.m). F Defective differentiation of brain MΦprogenitor in Lyl-1 mutant embryos. Distribution of A1-A2 and A3 MΦ subsets in E10 brain from Cx3cr1WT/GFP:Lyl-1WT/WT, Cx3cr1WT/GFP:Lyl-1WT/LacZ and
Cx3cr1WT/GFP:Lyl-1LacZ/LacZ embryos. The size of the whole MΦ population was similar in the three genotypes, but Lyl-1 deﬁciency modiﬁed the distribution
of the MΦ subsets with an increased size of the A1 subset and a reduced A3 pool (5-12 independent analyses, 6–8 brains per sample. Error bars show
mean ± s.e.m.; Unpaired, two-tailed t Test). G Heatmap expression proﬁle of the genes that mark the development of tissue resident-MΦs in WT E9 and
E10 MΦ-progenitors (Heatmap displays transformed log2-expression values; Unpaired, two-tailed t-test).

conﬁrmed the continuous expression of Lyl-1 in CD45low
microglia until adulthood (Supplementary Fig. 4a). LYL-1
expression was also reported in microglia from healthy murine
and human adults48–51. We examined the impact of Lyl-1-deﬁciency on microglia pool size during development. Microglia
quantiﬁcation pointed to E12 as the ﬁrst step impacted. The
arrested increase of microglia pool in Lyl-1LacZ/LacZ brain at E12
(Fig. 6a) resulted from a reduced proliferation (Fig. 6b) rather
than an increased apoptosis (Supplementary Fig. 4b). Moreover,
Lyl-1-deﬁciency provoked morphological changes in E12
Cx3cr1WT/GFP:Lyl-1LacZ/LacZ, compared to Cx3cr1WT/GFP microglia, namely a reduced number and extent of ramiﬁcations
(Fig. 6c; Supplementary Fig. 4c, d). From E14, the microglia pool
size returned to levels similar to WT (Fig. 6a), probably due to the
highly reduced apoptosis level in Lyl-1LacZ/LacZ microglia at E14
(Supplementary Fig. 4b).
P0-P3 was identiﬁed as a second stage altered in Lyl-1LacZ/LacZ
microglia. At birth, the cellularity of Lyl-1LacZ/LacZ brain was
signiﬁcantly decreased compared to WT (Fig. 6d), which was not
the case at earlier stages (Supplementary Fig. 4e). CD11b+ cells
recovery was also reduced (WT: 140.96 ± 0.91 × 103, n = 9; Lyl-1LacZ/
LacZ: 87.18 ± 0.37 × 103, n = 9). Consequently, Lyl-1-deﬁciency
triggered a nearly 2-fold reduction of the microglia population
(Fig. 6d). This perinatal reduction of microglia appeared transient,
since no difference with WT brain was observed in the adult
(Supplementary Fig. 4f). Transient decreases of microglia pool size,
such as those we observed at E12 and P0-P3 in Lyl-1LacZ/LacZ mutant,
have been reported to occur during normal development in postnatal
weeks 2–352, but also in Cx3cr1 mutant mice during the 1st postnatal
week53. This indicates a highly dynamic control of the microglia pool
size during key steps of neural development that seems preserved in
Lyl-1 mutant, with the exception of the E12 and P0-P3 time-points.
At this later stage, the reduction of brain cellularity in Lyl-1LacZ/LacZ
mice points to Lyl-1 as a possible regulator of the trophic function of
microglia on brain cells54,55.
The identiﬁcation of E12 and P0-P3 as key stages for Lyl-1
function in microglia development was conﬁrmed by RT-qPCR
analyses of the expression of genes essential for MΦs (Spi1/PU.1,
Csf1r, Mafb) and/or microglia (Runx1, Cx3cr1, Irf8) development
and function, of known regulators of developmental hematopoiesis (Tal-1, Lmo2, Runx1) and related factors (Tcf3/E2A, Tcf4/
E2.2) (Fig. 6e, f; Supplementary Fig. 4g). Time-course analyses
highlighted the down-regulation of Csf1r, Irf8 and Lmo2 in
Lyl-1LacZ/LacZ microglia at E12 and P0-P3, while Cx3cr1 was only
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decreased at E12 (Fig. 6g). Note that Lyl-1 expression was
unmodiﬁed in Cx3cr1GFP/GFP mutants (Fig. 6g). Interestingly,
Cx3cr1, as well as Irf8 and Lmo2, belong to potential Lyl-1 target
genes2.
Mafb expression levels in Lyl-1LacZ/LacZ microglia transiently
decreased at P0-P3 and later returned back to WT expression
levels (Fig. 6h). As Mafb represses resident-MΦ self-renewal56,
the recovery of a normal amount of microglia after birth may
stem from this transient decrease. Spi1/PU.1, Tcf3/E2A and Tcf4/
E2.2 expression levels were unmodiﬁed in Lyl-1LacZ/LacZ microglia, while Runx1 expression was only affected after birth. Tal-1
expression was decreased at E14 and increased after birth,
suggesting that this Lyl-1 paralog3 does not compensate Lyl-1deﬁciency during embryonic stages, but may do so at postnatal
stages (Supplementary Fig. 4g). Remarkably, RNA-seq. results
indicated that some genes deregulated in Lyl-1LacZ/LacZ microglia
at E12 and P0-P3 were also down-regulated in Lyl-1LacZ/LacZ
MΦ-progenitors at E9 (Csf1r: Supplementary Fig. 3c, Lmo2:
Fig. 3b; Irf8: Fig. 4D; Cx3cr1: Fig. 6i). These deregulations were
transient, however in both locations and stages they coincided
with a defective MΦ/microglia differentiation.
Other genes enriched in microglia (Fcrls, Mef2c, Maf)57 or
involved in the maintenance of microglia homeostasis (P2ry12)58
were also expressed in E9 Lyl-1LacZ/LacZ MΦ-progenitors at a
lower level than in the WT, except Lpr8 and Aif-1/Iba1 (Fig. 6i).
Interestingly, the lower expression of phagocytosis genes (Axl1,
Mertk, Trem2, P2y6r/P2ry6) uncovered in Lyl-1LacZ/LacZ MΦprogenitors from E10-YS (Fig. 4G), was present and stronger in
the microglia from Lyl-1LacZ/LacZ newborn, except for Trem2
which expression was unmodiﬁed (Fig. 6j).
These deregulations highlight again shared features between
MΦPrim progenitors and microglia/neural development which
became apparent upon Lyl-1 inactivation considering the large
number of neural signaling pathways up-regulated in E9 Lyl1LacZ/LacZ MΦ-progenitors (Fig. 3c) and the relationship of the
differentially expressed genes enriched in E9 MΦPrim progenitors
with brain formation and neuro-development uncovered in IPA
analysis (Supplementary Fig. 4h).
Based on the gene expression pattern of Lyl-1-deﬁcient
microglia and the signature of MΦPrim progenitors in the early
YS, a contribution of Lyl-1-deﬁciency to neurodevelopmental
disorders may be considered. Synaptic pruning and neural
maturation, which characterize the perinatal phase of microglia
development45, might be impaired in Lyl-1LacZ/LacZ embryos
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considering the defects observed at P0-P3, the later key
developmental stage regulated by Lyl-1. Indeed, Lyl-1 deregulation has been observed in datasets reporting pathological
models of brain myeloid cells (http://research-pub.gene.com/
BrainMyeloidLandscape/#Mouse-gene/Mouse-gene/17095/
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geneReport.html)59, as well as in human neuropathies60,61,
including the 19p13.13 micro-deletion neuro-developmental
disabilities62. However, since Lyl-1 is expressed in endothelial
cells, including in the brain42, a contribution of LYL-1-deﬁcient
endothelial cells to these diseases must be considered.
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Fig. 6 Lyl-1 deﬁciency leads to transient reductions of the microglia pool at E12 and P0-P3. a Quantiﬁcation of the microglia population in E12 and E14
brain showing the decreased size of the microglia pool at E12 and its recovery to a normal pool size at E14. (Each dot represents an independent
experiment. Error bars show mean ± s.e.m.; two tailed, unpaired t-test.) b The decreased microglia pool at E12 may result from a reduced proliferation, as
shown by the two folds decrease of BrdU-labeled cells in Lyl-1LacZ/LacZ compared to WT brains. (4 independent experiments; error bars show mean ± s.e.m.;
two tailed, unpaired Mann–Whitney test). c At E12, Cx3cr1WT/GFP:Lyl-1LacZ/LacZ microglia displayed a reduced number and extent of ramiﬁcations compared
to their Cx3cr1WT/GFP counterpart. Microglia morphology was classiﬁed into subtypes depending on the number of main ramiﬁcations (A: none, B: 2, C: 3
and D: > 3). Microglia deprived of ramiﬁcations predominated in Lyl-1-deﬁcient microglia. 65 and 61 cells were respectively acquired from the midbrain of
E12 Cx3cr1WT/GFP and Cx3cr1WT/GFP:Lyl-1LacZ/LacZ embryos (for each genotype, brains from 12 embryos were acquired in 3 independent experiments).
Microglia were identiﬁed by Cx3cr1-driven GFP expression and F4/80-APC immuno-staining. Bar = 10 μm. (Error bars show mean ± s.e.m.; two tailed,
unpaired t-test). d In Lyl-1LacZ/LacZ newborns, the cellularity of the brain was consistently lower than in WT, and so was the estimated microglia number. (3
independent experiments. Error bars show mean ± s.e.m.; two tailed, unpaired t-test). e Kinetic evolution of Lyl-1 expression levels in WT microglia from
embryonic stages to adulthood. Expression levels were normalized to the mean value obtained for E12 microglia (n = 3; error bars show mean ± s.e.m). An
increased expression of Lyl-1 from embryonic stages to adulthood was also inferred from timeline RNA-seq. data45. (GEO accession number GSE79812).
f Quantitative RT-PCR analyses also point to E12 and P0 as key development stages regulated by Lyl-1. CD11b+F4/80+CD45low microglia were isolated at
sequential development stages. Bar graphs show the kinetic of expression of genes modiﬁed in Lyl-1LacZ/LacZ microglia (arrowheads), normalized to the
mean expression value in WT E12 microglia (n = 3). Floating bars indicate mean ± s.e.m. Two tailed, unpaired t-test. g Cx3Cr1 and Lyl-1 expression in mutant
microglia. The expression level of Cx3CR1, analyzed as in f, was decreased in Lyl-1 mutants at E12, while Lyl-1 expression levels were unmodiﬁed in
CX3CR1GFP/GFP microglia at E12 and in newborns. h Mafb expression in mutant microglia. Mafb expression level, analyzed as in f, was reduced in the
microglia of Lyl-1LacZ/LacZ newborns. i The expression of genes enriched in microglia and/or essential for their function are deregulated in Lyl-1LacZ/LacZ MΦprogenitors at E9. Relative expression levels (read counts) in WT and Lyl-1lacZ/lacZ MΦ-progenitors from E9-YS. (3 independent experiments. Box and
whisker plots, min to max; median is shown; Unpaired, two-tailed t-Test). j Relative expression levels (read counts) of phagocytosis genes in sorted
microglia from WT and Lyl-1LacZ/LacZ newborn (Error bars show mean ± s.e.m.; one tailed unpaired t-test).

Table 1 Breeding crosses used throughout this study.

Table 2 Cytokines used in this study.

Genotype of the male

Cytokine

Lyl-1LacZ/LacZ
Lyl-1LacZ/LacZ
CX3CR1GFP/GFP
CX3CR1GFP/GFP
Lyl-1LacZ/
LacZ:CX3CR1GFP/GFP
Lyl-1LacZ/
LacZ:CX3CR1GFP/GFP

Genotype of
the female

Genotype of resulting
embryos-mice

WT
Lyl-1LacZ/LacZ
WT
Lyl-1LacZ/LacZ
WT

Lyl-1WT/LacZ
Lyl-1LacZ/LacZ
CX3CR1WT/GFP
Cx3cr1WT/GFP:Lyl-1WT/LacZ
Cx3cr1WT/GFP:Lyl-1WT/LacZ

Lyl-1LacZ/LacZ

Lyl-1LacZ/LacZ:CX3CR1WT/

GFP

Conclusions
Altogether, our ﬁndings reveal Lyl-1 as a key factor regulating the
production and differentiation of YS MΦ-progenitors and the
development of microglia. Lyl-1 is the least studied partners of
the transcription factor complex that regulates developmental
hematopoiesis. The development of more appropriate models is
required to precise Lyl-1 functions in microglia and determine its
role in the development of other resident-MΦs populations.
Methods
Mice. The following mouse strains, housed in Gustave Roussy Institute animal
facility (License #H94-076-11) were used (See Table 1 for a summary of the
breeding schemes): 1- C57BL/6 mice (Harlan or Charles Rivers Laboratories),
referred to as wild type (WT); 2- Lyl-1LacZ mice5. To avoid the possible detection of
FDG/Lyl-1 expression from maternally-derived MΦ11 in heterozygous embryos,
Lyl-1LacZ/LacZ males were crossed with WT females; 3- Cx3cr1GFP mice63.
Cx3cr1GFP/GFP males were crossed with WT females to generate Cx3cr1WT/GFP
mice/embryos or with Lyl-1LacZ/LacZ females to generate Cx3cr1WT/GFP:Lyl-1WT/
LacZ mice/embryos. 4-Cx3cr1GFP/GFP:Lyl-1LacZ/LacZ double mutant strain developed
from Cx3cr1WT/GFP:Lyl-1WT/LacZ crosses. Cx3cr1WT/GFP:Lyl-1WT/LacZ and
Cx3cr1WT/GFP:Lyl-1LacZ/LacZ mice/embryos were obtained by crossing Cx3cr1GFP/
GFP:Lyl-1LacZ/LacZ males respectively to C57BL/6 or Lyl-1LacZ/LacZ females.
Experiments were conducted in compliance with French/European laws, under
authorized project #2016-030-5798, approved by ofﬁcially accredited local institutional animal (committee n°26) and French “Ministère de la Recherche” ethics
boards..
The day of vaginal plug observation was considered as E0.5. Pregnant females
were sacriﬁced by cervical dislocation. Pre-somite embryos were staged according
to Downs et al.64, by somite counting from E8 to E10.5 and thereafter by
morphological landmarks.
12

Murine recombinant
cell factor
Human recombinant
Murine recombinant
Human recombinant

Concentration

Supplier

stem

50 ng/mL

Peprotech; Ref: 315-03

EPO
IL-3
IL-6

3 U/mL
10 ng/mL
10 ng/mL

In house production
Peprotech; Ref: 213-13
A gift from Sam Burstein,
Maryville, USA
Peprotech; Ref: 300-25
A gift from Kirin Brewery,
Tokyo, Japan

Human recombinant CSF-1
Human recombinant TPO

10 ng/mL
10 ng/mL

Tissues. Cells from the yolk sac (E7.5-E10.5), from E10 FL or whole brain (E9E14) were obtained after mechanical disruption9,65. For cytometry analyses, the
dissected region of the brain comprises the di-, mes- and metencephalon at E9-E10,
the ectoderm was carefully removed22. After E12, microglia were recovered from
the midbrain following Percoll (P1644, Sigma) separation66. Cells were ﬁltered
through a 70 μm cell strainer and centrifuged at 300 g for 10 min. Cells were
resuspended in Fc block BD solution and incubated at room temperature for
10 min. After washing in PBS + 10% FCS and centrifugation, cells were resuspended in 50 μl + 10% FCS containing the ﬂuorochrome coupled antibodies and
incubated at 4 °C for 20 min. After washing in PBS + 10%FCS and centrifugation,
cells were resuspended in 50ul + 10% FCS. Dead cells were excluded by adding
1 μg/mL DAPI (Sigma) before acquisition.
The number of microglia per brain was estimated by reporting the percentage of
CD11b+CD45lowF4/80+ microglia to the cellularity of the corresponding sample.
Tissue culture. YS explants, maintained for 1 day in organ culture in plates
containing OptiMEM+Glutamax, 1% Penicillin-streptomycin, 0.1% βmercaptoethanol (ThermoFisher) and 10% fetal calf serum (Hyclone), are referred
to as OrgD1-YS.
In clonogenic assays, YS suspension or sorted cells were plated in triplicate (3 ×
103 or 100-150 cells/mL) in Methocult® M3234 (StemCell Technologies) always
supplemented the cytokines listed in Table 2. Colonies were scored at day 5 for
primitive erythroblasts and day 7 for other progenitors.
Flow cytometry. Cells, stained with antibodies listed in Table 3, for 30 min. on ice,
were acquired (Canto II) or sorted (FACS-Aria III or Inﬂux, BD Biosciences) and
analyzed using FlowJo (Treestar) software.
The β-Galactosidase substrate ﬂuorescein di-β-galactopyranoside (FDG;
Molecular probe), was used as reporter for Lyl-1 expression in FACS-Gal assay67,68.
For apoptosis analysis, microglia were immune-stained and incubated with
Annexin V-FITC. 7AAD was added before acquisition. For proliferation assays,
pregnant females (12 gestational days) were injected with BrdU (10μM) and
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Table 3 Antibodies and ﬂuorescent stains used throughout this study.
Antibody name

Clone

Supplier/Reference

Fluorochrome/ Chromogen

Ter119

TER-119

F4/80

CD11b

BM8
CI:A3-1
BM8
BM8
RB6-8C5
RB6-8C5
RB6-8C5
30-F11
30-F11
30-F11
30-F11
MEC13.3
390
MEC13.3
MEC13.3
MEC13.3
2B8
2B8
2B8
M1/70

Sca-1
MHC-II
Annexin V
Anti-Brdu
7AAD
FDG

D7
M5/114.15.2
NA
B44
NA
NA

Biolegend; 116205
Biolegend; 116208
eBioscience 17-5921-82
eBioscience; 53-4801-82
Biolegend; 122606
eBioscience; 12-4801-82
Biolegend; 123116
BD-Pharmingen; 553127
Biolegend; 108416
Biolegend, 108437
BD-Pharmingen; 553081
BD-Pharmingen; 553082
eBioscience; 25-0451-82
Biolegend; 103124
Biolegend; 102514
Biolegend; 102408
Biolegend; 102419
Biolegend; 102516
BD-Pharmingen; 583089
Biolegend; 05824
BD-Pharmingen; 553358
Biolegend; 105825
eBioscience; 45-0112-82
Biolegend; 101215
Biolegend; 101212
eBioscience; 47-0112-82
Biolegend; 108113
Biolegend; 107607
Biolegend; B206040
BD-Pharmingen; 51-23619 L
BD-Pharmingen; 51-68981E
Molecular probe; Thermo Fisher; F1179

FITC
PE
APC
Alexa ﬂuor 488
FITC
PE
APC
FITC
PE-Cy7
BV510
PE
PE-Cy5
PE-Cy7
Alexa ﬂuor 647
Alexa ﬂuor 488
PE
PE-Cy5.5
Alexa ﬂuor 647
BV510
Alexa ﬂuor 488
APC
APC-Cy7
PE-Cy5.5
PE-Cy7
APC
APC-eFluor 780
PE-Cy7
PE
FITC
APC
Dye
Dye

GR-1

CD45

CD31

Kit

sacriﬁced 2 h later. Microglia were isolated, immune-stained and prepared
according to kit instruction (BD Pharmingen 552598). BrdU incorporation was
revealed using anti-BrdU-APC.
Brain imaging. To assess microglia morphology in E12 embryos, the midbrain was
dissected from Cx3cr1WT/GFP:Lyl-1WT/WT and Cx3cr1WT/GFP:Lyl-1LacZ/LacZ
embryos and sectioned through the midline. After ﬁxation (4% paraformaldehyde)
overnight at 4 °C, whole midbrains were washed in phosphate-buffered saline
(PBS)/0.1 M glycine and incubated overnight in PBS/15% sucrose at 4 °C. Midbrains were washed with PBS + 0.1% Tween and incubated 90 min. in blocking
buffer (PBS + 10% FCS) at room temperature (RT). Midbrains were subsequently
immune-labeled with F4/80-APC overnight at 4 °C. After washing, they were
incubated 3 min. in PBS + DAPI (1 μg/mL) at RT and washed. Finally, midbrains
were placed in the central well of glass-bottom culture dishes (P35G-1.5-10-C;
MatTek, USA) ﬁlled with PBS + 10% FCS. After appropriate orientation of the
sample, the well was covered with a 12 μm ∅ glass coverslip. Image stacks were
collected using a Leica SP8 confocal microscope. To unsure an unbiased choice of
the cells imaged, taking into account possible changes in cell distribution induced
by Lyl-1 deﬁciency, we always acquired cells in similar positions regarding the
landmark set in the midbrain ﬂat mount, as shown in Supplementary data and
Fig. 4C. Images were processed using Imaris x64 (version 7.7.2; Bitplane) and
Photoshop 8.0 (Adobe Systems, San Jose, CA) softwares.
RT-qPCR analyses. RNA was extracted using Trizol. After cDNA synthesis
(SuperScript™ VILO™ Master-Mix reverse transcriptase, ThermoFisher), Real Time
(RT)-PCR was performed (SYBR Premix Ex TaqII, Takara Bio). Reference genes
were Actin, Hprt and Tubulin. Gene expressions were normalized to the values
obtained for E10-YS MΦ-progenitors, E12 WT Lin-Sca+cKit+ (LSK) progenitors
or E12 WT microglia. Primers are listed in Table 4.
RNA-seq. For samples preparation, MΦ-progenitors (Kit+CD45+CD11b+) were
sorted from E9 (MΦPrim progenitor) and E10 (MΦPrim + MΦT-Def progenitors) YS
pools from WT or Lyl-1LacZ/LacZ embryos (Four biological replicates). RNA was
extracted as described above.
The RNA integrity (RNA Integrity Score ≥ 7.0) was checked on the Agilent
2100 Bioanalyzer (Agilent) and quantity was determined using Qubit (Invitrogen).

SureSelect Automated Strand Speciﬁc RNA Library Preparation Kit was used
according to manufacturer’s instructions with the Bravo Platform. Brieﬂy, 50 ng of
total RNA sample was used for poly-A mRNA selection using oligo(dT) beads and
subjected to thermal mRNA fragmentation. Fragmented mRNA samples were
subjected to cDNA synthesis and converted into double stranded DNA using
reagents supplied in the kit. The resulting dsDNA was used for library preparation.
The ﬁnal libraries were bar-coded, puriﬁed, pooled together in equal
concentrations and subjected to paired-end sequencing (2 × 100) on Novaseq-6000
sequencer (Illumina) at Gustave Roussy genomic facility.
The quality of RNA-seq. reads were assessed with FastQC 0.11.7 and MultiQC
1.569. Low quality reads were trimmed with Trimmomatic 0.3370. Salmon 0.9.0
tool71 was used for quantifying the expression of transcripts using geneset
annotation from Gencode project release M17 for mouse72. The version of
transcriptome reference sequences used was GRCm38.p6.
Statistical analysis was performed using R with the method proposed by Anders
and Huber implemented in the DESeq2 Bioconductor package73. The differential
expression analysis in DESeq2 uses a generalized linear model (GLM) where counts
are modeled using a negative binomial distribution. Counts were normalized from
the estimated size factors using the median ratio method and a Wald test was used
to test the signiﬁcance of GLM coefﬁcients. Genes were considered differentially
expressed when adjusted p-value < 0.05 and fold-change > 2.
Data were analyzed through the use of Ingenuity® Pathway Analysis (QIAGEN
Inc., https://www.qiagenbioinformatics.com/products/ingenuity-pathwayanalysis)74, Gene set enrichment analysis (GSEA; https://www.gsea-msigdb.org/
gsea/index.jsp)75,76, Morpheus (https://software.broadinstitute.org/morpheus/) and
Venny (https://bioinfogp.cnb.csic.es/tools/venny/) softwares.

Statistics and reproducibility. Statistical analyses including mean, SEM and p
values were performed using using Prism 7 software (GraphPad). Statistical signiﬁcance between two groups was assessed by unpaired two-tailed Student’s t tests
or Mann–Whitney tests. Data are presented as mean ± SEM or by Box and whisker
plots, min to max, with the median shown. Statistical signiﬁcances were indicated
by p-values and/or as *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, ns:
not signiﬁcant). P-values below 0.05 were considered as signiﬁcantly different. The
number of biological replicates (n) and independent experiments is reported in the
corresponding ﬁgure legend.
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Table 4 Primers used in this study.
Gene
Actin
Hprt

Tubulin
c-Maf
Lyl-1
Tal-1/Scl
Runx1
Meis1
Lmo2
PU.1
Tcf3/E2A
Tcf4/E2.2
Csf1r
Cx3cr1
Irf8
Myb
Axl
MertK
Trem2
P2y6r/P2ry6

Sequence
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer
Primer

forward:
reverse:
forward:
reverse:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:
forward:
reverse:

Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
The authors declare that all data supporting the ﬁndings of this study are available within
the article and its supplementary information ﬁles or from the corresponding author
upon reasonable request. RNAseq data have been deposited in the ArrayExpress database
at EMBL-EBI (www.ebi.ac.uk/arrayexpress) under accession code E-MTAB-9618. The
source data underlying ﬁgures and supplementary ﬁgures are provided as a
Supplementary Data 1.
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